Status:
COMPLETED
Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation
Lead Sponsor:
Cairo University
Conditions:
Premature Ejaculation
Eligibility:
MALE
20-60 years
Phase:
PHASE3
Brief Summary
This randomized controlled cross-over study aims to evaluate the effect and safety of glans penis augmentation using Hyaluronic acid in the treatment of premature ejaculation in compare with placebo .
Eligibility Criteria
Inclusion
- occurrence of ejaculation in patients with lifelong premature ejaculation (LL PE) within 1 minute form vaginal penetration in all or almost all occasions starting from the first sexual experience, and within 3 minutes in patients with acquired premature ejaculation (A PE), along with inability to delay ejaculation on all or nearly all vaginal penetrations, with negative personal consequences, such as distress, bother, frustration, and/or the avoidance of sexual intimacy
Exclusion
- Erectile dysfunction
- Hypo or hyperthyroidism
- Hypogonadism
- Hyperprolactinemia
- Drug abuse
- Psychiatric disorders or related medications
Key Trial Info
Start Date :
August 19 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03459833
Start Date
August 19 2016
End Date
March 1 2018
Last Update
March 13 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.